Decreased secretion of TNF-α, IL-6; increased Siglec-E expression; increased serum IL-10; decreased serum IL-6; increased survival benefit in LPS-induced endotoxemia. The gene discussed is IL6; the disease is serum lipopolysaccharide activity.